FS
Insider
Farrell Simon
Chief Commercial OfficerFarrell Simon (Chief Commercial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Trevi Therapeutics, Inc. (TRVI). The largest single filing was $518K of TRVI (76,963 sh × $6.73, as filed), executed Mar 10 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$518K
shares × price, as filed
Last traded
Mar 10 2025
Filed Mar 12 2025
Median ADV $33.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $518K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
TRVIRecent filings
TRVISALE
Trevi Therapeutics, Inc.
View filing →
$518K76,963 sh × $6.73
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET